|
1
|
Charlton J, Irtan S, Bergeron C and
Pritchard-Jones K: Bilateral Wilms tumour: A review of clinical and
molecular features. Expert Rev Mol Med. 19:e82017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dome JS, Perlman EJ and Graf N: Risk
stratification for wilms tumor: current approach and future
directions. Am Soc Clin Oncol Educ Book. 215–223. 2014. View Article : Google Scholar
|
|
3
|
Dumba M, Jawad N and McHugh K:
Neuroblastoma and nephroblastoma: A radiological review. Cancer
Imaging. 15:52015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szychot E, Apps J and Pritchard-Jones K:
Wilms' tumor: Biology, diagnosis and treatment. Transl Pediatr.
3:12–24. 2014.PubMed/NCBI
|
|
5
|
Maschietto M, Piccoli FS, Costa CM,
Camargo LP, Neves JI, Grundy PE, Brentani H, Soares FA, de Camargo
B and Carraro DM: Gene expression analysis of blastemal component
reveals genes associated with relapse mechanism in Wilms tumour.
Eur J Cancer. 47:2715–2722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Francois M, Donovan P and Fontaine F:
Modulating transcription factor activity: Interfering with
protein-protein interaction networks. Semin Cell Dev Biol.
99:12–19. 2020. View Article : Google Scholar
|
|
7
|
Teschendorff AE, Zheng SC, Feber A, Yang
Z, Beck S and Widschwendter M: The multi-omic landscape of
transcription factor inactivation in cancer. Genome Med. 8:892016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holland PW: Evolution of homeobox genes.
Wiley Interdiscip Rev Dev Biol. 2:31–45. 2013. View Article : Google Scholar
|
|
9
|
Yu HY and Pan SS: MiR-202-5p suppressed
cell proliferation, migration and invasion in ovarian cancer via
regulating HOXB2. Eur Rev Med Pharmacol Sci. 24:2256–2263.
2020.
|
|
10
|
Du H, Bao Y, Liu C, Zhong A, Niu Y and
Tang X: MiR1395p enhances cisplatin sensitivity in nonsmall cell
lung cancer cells by inhibiting cell proliferation and promoting
apoptosis via the targeting of Homeobox protein HoxB2. Mol Med Rep.
23:1042021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jing P, Zou J, Zhang L, Wang C, Yang Y,
Deng L and Zhao D: HOXB2 and FOXC1 synergistically drive the
progression of Wilms tumor. Exp Mol Pathol. 115:1044692020.
View Article : Google Scholar
|
|
12
|
Raemaekers T, Ribbeck K, Beaudouin J,
Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg
J and Carmeliet G: NuSAP, a novel microtubule-associated protein
involved in mitotic spindle organization. J Cell Biol.
162:1017–1029. 2003. View Article : Google Scholar
|
|
13
|
Zhou Q, Lee KJ, Kurasawa Y, Hu H, An T and
Li Z: Faithful chromosome segregation in Trypanosoma brucei
requires a cohort of divergent spindle-associated proteins with
distinct functions. Nucleic Acids Res. 46:8216–8231. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Guan C, Lu C, Liu Y, Ni R, Xiao M
and Bian Z: High NUSAP1 expression predicts poor prognosis in colon
cancer. Pathol Res Pract. 214:968–973. 2018. View Article : Google Scholar
|
|
15
|
Zheng H, Li BH, Liu C, Jia L and Liu FT:
Comprehensive analysis of lncRNA-Mediated ceRNA crosstalk and
identification of prognostic biomarkers in Wilms' tumor. Biomed Res
Int. 2020:49516922020.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cunningham ME, Klug TD, Nuchtern JG,
Chintagumpala MM, Venkatramani R, Lubega J and Naik-Mathuria BJ:
Global disparities in Wilms tumor. J Surg Res. 247:34–51. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aghaalikhani N, Rashtchizadeh N, Shadpour
P, Allameh A and Mahmoodi M: Cancer stem cells as a therapeutic
target in bladder cancer. J Cell Physiol. 234:3197–3206. 2019.
View Article : Google Scholar
|
|
19
|
Barbato L, Bocchetti M, Di Biase A and
Regad T: Cancer stem cells and targeting strategies. Cells.
8:9262019. View Article : Google Scholar
|
|
20
|
Liu X, Chen Y, Li Y, Petersen RB and Huang
K: Targeting mitosis exit: A brake for cancer cell proliferation.
Biochim Biophys Acta Rev Cancer. 1871:179–191. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mills CA, Suzuki A, Arceci A, Mo JY,
Duncan A, Salmon ED and Emanuele MJ: Nucleolar and
spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3
ligase complex during chromosome segregation. J Biol Chem.
292:17178–17189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun L, Shi C, Liu S, Zhang E, Yan L, Ji C
and Zhao Y: Overexpression of NuSAP1 is predictive of an
unfavourable prognosis and promotes proliferation and invasion of
triple-negative breast cancer cells via the Wnt/β-catenin/EMT
signalling axis. Gene. 747:1446572020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan S, Zhan Y, Chen X, Wu B and Liu B:
Identification of biomarkers for controlling cancer stem cell
characteristics in bladder cancer by network analysis of
transcriptome data stemness indices. Front Oncol. 9:6132019.
View Article : Google Scholar
|
|
24
|
Shen J, Yu S, Sun X, Yin M, Fei J and Zhou
J: Identification of key biomarkers associated with development and
prognosis in patients with ovarian carcinoma: Evidence from
bioinformatic analysis. J Ovarian Res. 12:1102019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Zhang W, Kadier A, Zhang H and Yao
X: MicroRNA-769-5p suppresses cell growth and migration via
targeting NUSAP1 in bladder cancer. J Clin Lab Anal.
34:e231932020.
|
|
26
|
Boimel PJ, Cruz C and Segall JE: A
functional in vivo screen for regulators of tumor progression
identifies HOXB2 as a regulator of tumor growth in breast cancer.
Genomics. 98:164–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Inamura K, Togashi Y, Ninomiya H, Shimoji
T, Noda T and Ishikawa Y: HOXB2, an adverse prognostic indicator
for stage I lung adenocarcinomas, promotes invasion by
transcriptional regulation of metastasis-related genes in HOP-62
non-small cell lung cancer cells. Anticancer Res. 28((4B)):
2121–2127. 2008.PubMed/NCBI
|
|
28
|
Pan X, Liu W, Chai Y, Wang J and Zhang Y:
Genetic and clinical characterization of HOXB2 in glioma. Onco
Targets Ther. 13:10465–10473. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li M, Wang JF, Liu B and Wang XM: Homeobox
B2 is a potential prognostic biomarker of glioblastoma. Rev Assoc
Med Bras (1992). 66:794–799. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Z, Wang Y, Xiong J, Cui F, Wang L and
Peng H: NUSAP1 knockdown inhibits cell growth and metastasis of
non-small-cell lung cancer through regulating BTG2/PI3K/Akt
signaling. J Cell Physiol. 235:3886–3893. 2020. View Article : Google Scholar
|
